1-13 of 13
W. Mark Saltzman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR-01: Systemic targeting of therapeutic RNA to pancreatic ductal adenocarcinoma via a novel, cell-penetrating, and nucleic acid-binding monoclonal antibody

Diana Martinez-Saucedo, Elias Quijano, Zaira Ianniello, Madison Rackear, Yanfeng Liu, Denise Hegan, Haoting Chen, Xinning Shan, Robert Tseng, Deanne Yugawa, Natasha Pinto-Medici, Sumedha Chowdhury, Ranjit S Bindra, Marie E Robert, W. Mark Saltzman, Luisa F Escobar-Hoyos, Peter M Glazer
Journal: Cancer Research
Cancer Res (2024) 84 (17_Supplement_2): PR-01.
https://doi.org/10.1158/1538-7445.PANCREATIC24-PR-01
Published: 15 September 2024
View articletitled, Abstract PR-01: Systemic targeting of therapeutic RNA to pancreatic ductal adenocarcinoma via a novel, cell-penetrating, and nucleic acid-binding monoclonal antibody
Journal Articles

Abstract 7117: Convection enhanced delivery of a novel ATR inhibitor synergizes with systemic lomustine for improved treatment of glioblastoma

Alexander Josowitz, Teresa Lee, Ranjini K. Sundaram, Jinal Pothupitiya, Eric J. Brown, Amrita Sule, Jason Beckta, Yongheng Wang, Joseph Vacca, Oren Gilad, Ranjit S. Bindra, W Mark Saltzman
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7117.
https://doi.org/10.1158/1538-7445.AM2024-7117
Published: 22 March 2024
View articletitled, Abstract 7117: Convection enhanced delivery of a novel ATR inhibitor synergizes with systemic lomustine for improved treatment of glioblastoma
Journal Articles

Abstract 294: Exploiting mutant PPM1D-induced metabolic defects with nanoparticle-encapsulated NAMPT inhibitors

Matthew Murray, Yazhe Wang, Ranjini K. Sundaram, Jason Beckta, W. Mark Saltzman, Ranjit S. Bindra
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 294.
https://doi.org/10.1158/1538-7445.AM2022-294
Published: 15 June 2022
View articletitled, Abstract 294: Exploiting mutant PPM1D-induced metabolic defects with nanoparticle-encapsulated NAMPT inhibitors
Journal Articles

Abstract 663: Systemic targeting of therapeutic RNA to cancer via a novel, cell-penetrating and nucleic acid binding, monoclonal antibody

Elias Quijano, Diana Martinez Saucedo, Minsoo Khang, Yanfeng Liu, Dale Ludwig, Bruce C. Turner, Stephen Squinto, Ranjit Bindra, W. Mark Saltzman, Luisa Escobar-Hoyos, Peter M. Glazer
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 663.
https://doi.org/10.1158/1538-7445.AM2022-663
Published: 15 June 2022
View articletitled, Abstract 663: Systemic targeting of therapeutic RNA to cancer via a novel, cell-penetrating and nucleic acid binding, monoclonal antibody
Journal Articles

Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors

Cecilia Lopez Sambrooks, Marta Baro, Amanda Quijano, Azeet Narayan, Wei Cui, Patricia Greninger, Regina Egan, Abhijit Patel, Cyril H. Benes, W. Mark Saltzman, Joseph N. Contessa
Journal: Cancer Research
Cancer Res (2018) 78 (17): 5094–5106.
https://doi.org/10.1158/0008-5472.CAN-18-0505
Published: 04 September 2018
View articletitled, Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
Open the PDF for Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract B46: Surface chemistry governs cellular tropism of nanoparticles in the brain

Eric Song, Alice Gaudin, Amanda R. King, Youngeun Seo, Paul Won, Heewon Suh, Yang Deng, Jiajia Cui, Gregory Tietjen, W Mark Saltzman
Journal: Cancer Research
Cancer Res (2017) 77 (2_Supplement): B46.
https://doi.org/10.1158/1538-7445.EPSO16-B46
Published: 16 January 2017
View articletitled, Abstract B46: Surface chemistry governs cellular tropism of nanoparticles in the brain
Journal Articles

Abstract 1075: Chemically modified gamma PNAs targeting oncomiR-210 as a potential anticancer therapy

Anisha Gupta, Yanfeng Liu, Elias E. Quijano, W Mark Saltzman, Peter M. Glazer
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1075.
https://doi.org/10.1158/1538-7445.AM2016-1075
Published: 15 July 2016
View articletitled, Abstract 1075: Chemically modified gamma PNAs targeting oncomiR-210 as a potential anticancer therapy
Journal Articles

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer

Brian D. Adams, Vikram B. Wali, Christopher J. Cheng, Sachi Inukai, Carmen J. Booth, Seema Agarwal, David L. Rimm, Balázs Győrffy, Libero Santarpia, Lajos Pusztai, W. Mark Saltzman, Frank J. Slack
Journal: Cancer Research
Cancer Res (2016) 76 (4): 927–939.
https://doi.org/10.1158/0008-5472.CAN-15-2321
Published: 14 February 2016
View articletitled, miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
Open the PDF for miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A21: High-throughput small molecule screening of genetically diverse glioblastoma stem cells

Garth W. Strohbehn, Jiangbing Zhou, Michael Fu, Toral R. Patel, Joseph M. Piepmeier, W. Mark Saltzman
Journal: Cancer Research
Cancer Res (2012) 72 (13_Supplement): A21.
https://doi.org/10.1158/1538-7445.CSB12-A21
Published: 06 November 2014
View articletitled, Abstract A21: High-throughput small molecule screening of genetically diverse glioblastoma stem cells
Journal Articles

Abstract 364: In vivo targeting of CD44+ ovarian cancer stem cells (CSC) by Clostridium Perfringens Enterotoxin binding domain (CPE-peptide) conjugated to poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NP)

Emiliano Cocco, Stefania Bellone, Dana Roque, Federica Guzzo, Sara Gasparrini, Sergio Pecorelli, Dan-Arin Silasi, Masoud Azodi, Elena Ratner, Thomas Ruterford, Peter Schwartz, Caroline E. Weller, W. Mark Saltzman, Alessandro D. Santin
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 364.
https://doi.org/10.1158/1538-7445.AM2012-364
Published: 15 April 2012
View articletitled, Abstract 364: In vivo targeting of CD44+ ovarian cancer stem cells (CSC) by Clostridium Perfringens Enterotoxin binding domain (CPE-peptide) conjugated to poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NP)
Journal Articles

Abstract 4747: Redirecting the endogenous immune response against prostate cancer using an antibody-recruiting small molecule

Andrew X. Zhang, Christopher J. Hoimes, Ryan P. Murelli, W. Mark Saltzman, David A. Spiegel
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4747.
https://doi.org/10.1158/1538-7445.AM2012-4747
Published: 15 April 2012
View articletitled, Abstract 4747: Redirecting the endogenous immune response against prostate cancer using an antibody-recruiting small molecule
Journal Articles

Pharmacokinetics of Interstitial Delivery of Carmustine, 4-Hydroperoxycyclophosphamide, and Paclitaxel from a Biodegradable Polymer Implant in the Monkey Brain

Lawrence K. Fung, Matthew G. Ewend, Allen Sills, Eric P. Sipos, Reid Thompson, Mark Watts, O. Michael Colvin, Henry Brem, W. Mark Saltzman
Journal: Cancer Research
Cancer Res (1998) 58 (4): 672–684.
Published: 01 February 1998
View articletitled, Pharmacokinetics of Interstitial Delivery of Carmustine, 4-Hydroperoxycyclophosphamide, and Paclitaxel from a Biodegradable Polymer Implant in the Monkey Brain
Open the PDF for Pharmacokinetics of Interstitial Delivery of Carmustine, 4-Hydroperoxycyclophosphamide, and Paclitaxel from a Biodegradable Polymer Implant in the Monkey Brain in another window
Journal Articles

Covalent Coupling of Methotrexate to Dextran Enhances the Penetration of Cytotoxicity into a Tissue-like Matrix

Wenbin Dang, O. Michael Colvin, Henry Brem, W. Mark Saltzman
Journal: Cancer Research
Cancer Res (1994) 54 (7): 1729–1735.
Published: 01 April 1994
View articletitled, Covalent Coupling of Methotrexate to Dextran Enhances the Penetration of Cytotoxicity into a Tissue-like Matrix
Open the PDF for Covalent Coupling of Methotrexate to Dextran Enhances the Penetration of Cytotoxicity into a Tissue-like Matrix in another window